GLOBAL EUBIOTICS MARKET 2021-2028

Lifesciences | Healthcare & Wellness

GLOBAL EUBIOTICS MARKET 2021-2028

Market by Type, Form, Livestock, Application, End-user, and Geography | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Eubiotics are types of feed additives comprising prebiotics, probiotics, essential oils, and organic acids. The primary goal of administering eubiotics is to maintain intestine eubiosis, resulting in enhanced health and performance in farm animals. Besides, it has proven to be a viable alternative to antibiotics. As per Triton Market Research, the global market for eubiotics was valued at $4239.22 million in 2020 and is expected to reach $7521.10 million by 2028, growing at a CAGR of 7.43% during the forecast period.


Report scope can be customized per your requirements. Request For Customization

Triton’s report on eubiotics provides an in-depth insight into the market. The detailed analysis of the market includes key insights, Porter’s five forces analysis, market attractiveness index, vendor scorecard, key strategies, and impact of COVID-19 on the eubiotics market.

The studied market is driven by several factors such as rising meat consumption, growing awareness and concerns regarding animal health, and increasing demand for manufactured feeds. Here, the rising meat consumption due to the growing global population, industrialization, and shifting consumer habits have increased the demand for eubiotics. Besides, meat production has surged fourfold over the years globally. As per estimates, poultry (mainly chicken), pig meat, and beef make up over 92% of global meat production. Moreover, over 300 million cattle and 1.5 billion pigs are slaughtered for human meat consumption annually. Further, the increased meat consumption has raised concerns regarding meat quality, encouraging consumers to utilize eubiotics to produce healthy meat.

Furthermore, in recent years, eubiotics have emerged as a potential solution to the issue of antimicrobial resistance (AMR) since the spread of antibiotic resistance has become a global hazard. In addition, eubiotics include a multitude of beneficial chemicals that improve gut health and reinforce the protective layers of the GI tract. As a result, eubiotics are widely used in calves, aiding their growth and development. Moreover, eubiotics treat necrotic enteritis, one of the biggest gut health issues chicken farmers face, leading to enormous economic losses.

Conversely, the market has been impacted due to unawareness relating to eubiotics. Animal production in several nations is threatened by antibiotics, contributing to the growth of antimicrobial resistance (AMR). Moreover, farmers continue to use antibiotics despite bans in many countries. Besides, several farmers are unaware of the harmful consequences of antibiotics and the efficacy of eubiotics. Hence, the lack of awareness about the benefits of eubiotics puts the global market at risk.



Major geographies covered in the global eubiotics market are:

•           North America: United States and Canada

•           Europe: United Kingdom, France, Germany, Spain, Italy, Russia, and Rest of Europe

•           Asia-Pacific: China, Japan, India, Australia & New Zealand, South Korea, ASEAN Countries, and Rest of Asia-Pacific

•           Latin America: Brazil, Mexico, and Rest of Latin America

•           Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle East & Africa

The segmentation analysis of the eubiotics market includes:

•           Type segment includes:

           o          Probiotics 

           o          Organic Acid

           o          Prebiotics

           o          Essential Oils

•           Form segment includes:

           o          Dry

           o          Liquid

•           Livestock segment includes:

           o          Swine

           o          Poultry

           o          Ruminants

           o          Aquaculture

           o          Other Livestock

•           Application segment includes:

           o          Gut Health

           o          Immunity

           o          Yield Management

           o          Other Applications

•           End-user segment includes:

           o          Animals

           o          Humans

The distinguished companies thriving in the eubiotics market comprises BASF SE, Cargill Inc, Dupont De Nemours Inc, Koninklijke DSM NV, Archer Daniels Midland, Beneo GmbH, Neospark Drugs and Chemicals Private Limited, Kemin Industries Inc, Behn Meyer Group, Lesaffre, Novus International Inc, Yara International ASA, Anpario Plc, Lallemand Inc, and CHR Hansen Holding AS.   

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT
ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028
Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. GLOBAL EUBIOTICS MARKET - SUMMARY          

2. INDUSTRY OUTLOOK  

2.1. IMPACT OF COVID-19 ON EUBIOTICS MARKET    

2.2. KEY INSIGHTS      

2.2.1. EUBIOTICS AS AN ALTERNATIVE TO ANTIBIOTICS

2.2.2. APPLICATIONS OF EUBIOTICS IN CALVES’ GUT HEALTH

2.2.3. DEVELOPING FOOD ADDITIVE PLATFORM BASED ON GRAINS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS    

2.3.2. THREAT OF SUBSTITUTES         

2.3.3. BARGAINING POWER OF BUYERS      

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY  

2.4. MARKET ATTRACTIVENESS INDEX  

2.5. VENDOR SCORECARD 

2.6. KEY MARKET STRATEGIES     

2.6.1. MERGERS & ACQUISITIONS      

2.6.2. CONTRACTS & AGREEMENTS  

2.6.3. PRODUCT LAUNCHES    

2.6.4. EXPANSIONS         

2.7. MARKET DRIVERS         

2.7.1. RISING MEAT CONSUMPTION   

2.7.2. GROWING AWARENESS AND CONCERNS REGARDING ANIMAL HEALTH     

2.7.3. INCREASING DEMAND FOR MANUFACTURED FEEDS     

2.8. MARKET CHALLENGES

2.8.1. UNAWARENESS ABOUT EUBIOTICS   

2.9. MARKET OPPORTUNITIES       

2.9.1. GOVERNMENT SUPPORT FOR EUBIOTICS USE     

2.9.2. PROBIOTICS SPRAY COATINGS           

2.9.3. ESSENTIAL OILS FOR NECROTIC ENTERITIS          

3. GLOBAL EUBIOTICS MARKET OUTLOOK - BY TYPE     

3.1. PROBIOTICS         

3.2. ORGANIC ACID    

3.3. PREBIOTICS         

3.4. ESSENTIAL OILS 

4. GLOBAL EUBIOTICS MARKET OUTLOOK - BY FORM    

4.1. DRY 

4.2. LIQUID        

5. GLOBAL EUBIOTICS MARKET OUTLOOK - BY LIVESTOCK     

5.1. SWINE        

5.2. POULTRY  

5.3. RUMINANTS         

5.4. AQUACULTURE   

5.5. OTHER LIVESTOCK        

6. GLOBAL EUBIOTICS MARKET OUTLOOK - BY APPLICATION 

6.1. GUT HEALTH        

6.2. IMMUNITY  

6.3. YIELD MANAGEMENT    

6.4. OTHER APPLICATIONS 

7. GLOBAL EUBIOTICS MARKET OUTLOOK - BY END-USER      

7.1. ANIMALS    

7.2. HUMANS    

8. GLOBAL EUBIOTICS MARKET – REGIONAL OUTLOOK 

8.1. NORTH AMERICA

8.1.1. MARKET BY TYPE 

8.1.2. MARKET BY FORM

8.1.3. MARKET BY LIVESTOCK 

8.1.4. MARKET BY APPLICATION         

8.1.5. MARKET BY END-USER  

8.1.6. COUNTRY ANALYSIS       

8.1.6.1. UNITED STATES       

8.1.6.2. CANADA         

8.2. EUROPE    

8.2.1. MARKET BY TYPE 

8.2.2. MARKET BY FORM

8.2.3. MARKET BY LIVESTOCK 

8.2.4. MARKET BY APPLICATION         

8.2.5. MARKET BY END-USER  

8.2.6. COUNTRY ANALYSIS       

8.2.6.1. UNITED KINGDOM    

8.2.6.2. GERMANY      

8.2.6.3. FRANCE          

8.2.6.4. SPAIN  

8.2.6.5. ITALY    

8.2.6.6. RUSSIA

8.2.6.7. REST OF EUROPE   

8.3. ASIA-PACIFIC       

8.3.1. MARKET BY TYPE 

8.3.2. MARKET BY FORM

8.3.3. MARKET BY LIVESTOCK 

8.3.4. MARKET BY APPLICATION         

8.3.5. MARKET BY END-USER  

8.3.6. COUNTRY ANALYSIS       

8.3.6.1. CHINA  

8.3.6.2. JAPAN 

8.3.6.3. INDIA    

8.3.6.4. SOUTH KOREA         

8.3.6.5. ASEAN COUNTRIES

8.3.6.6. AUSTRALIA & NEW ZEALAND      

8.3.6.7. REST OF ASIA-PACIFIC      

8.4. LATIN AMERICA  

8.4.1. MARKET BY TYPE 

8.4.2. MARKET BY FORM

8.4.3. MARKET BY LIVESTOCK 

8.4.4. MARKET BY APPLICATION         

8.4.5. MARKET BY END-USER  

8.4.6. COUNTRY ANALYSIS       

8.4.6.1. BRAZIL

8.4.6.2. MEXICO           

8.4.6.3. REST OF LATIN AMERICA 

8.5. MIDDLE EAST AND AFRICA     

8.5.1. MARKET BY TYPE 

8.5.2. MARKET BY FORM

8.5.3. MARKET BY LIVESTOCK 

8.5.4. MARKET BY APPLICATION         

8.5.5. MARKET BY END-USER  

8.5.6. COUNTRY ANALYSIS       

8.5.6.1. UNITED ARAB EMIRATES  

8.5.6.2. SAUDI ARABIA          

8.5.6.3. TURKEY          

8.5.6.4. SOUTH AFRICA         

8.5.6.5. REST OF MIDDLE EAST & AFRICA          

9. COMPETITIVE LANDSCAPE 

9.1. ANPARIO PLC                  

9.2. ARCHER DANIELS MIDLAND   

9.3. BASF SE                

9.4. BEHN MEYER GROUP               

9.5. BENEO GMBH                  

9.6. CARGILL INC        

9.7. CHR HANSEN HOLDING AS                 

9.8. DUPONT DE NEMOURS INC    

9.9. KEMIN INDUSTRIES INC

9.10. KONINKLIJKE DSM NV            

9.11. LALLEMAND INC           

9.12. LESAFFRE          

9.13. NEOSPARK DRUGS AND CHEMICALS PRIVATE LIMITED                     

9.14. NOVUS INTERNATIONAL INC

9.15. YARA INTERNATIONAL ASA              

10. RESEARCH METHODOLOGY & SCOPE  

10.1. RESEARCH SCOPE & DELIVERABLES                  

10.2. SOURCES OF DATA                 

10.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: GLOBAL EUBIOTICS MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: COUNTRIES WITH THE HIGHEST ANNUAL MEAT CONSUMPTION

TABLE 4: MAJOR LIVESTOCK DISEASES IN THE WORLD

TABLE 5: GLOBAL EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)

TABLE 7: GLOBAL EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 9: GLOBAL EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL EUBIOTICS MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)

TABLE 11: NORTH AMERICA EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 13: NORTH AMERICA EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)

TABLE 15: NORTH AMERICA EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 16: NORTH AMERICA EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 17: EUROPE EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 18: EUROPE EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 19: EUROPE EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)

TABLE 20: EUROPE EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)

TABLE 21: EUROPE EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 22: EUROPE EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 23: ASIA-PACIFIC EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 24: ASIA-PACIFIC EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 25: ASIA-PACIFIC EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)

TABLE 26: ASIA-PACIFIC EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)

TABLE 27: ASIA-PACIFIC EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 28: ASIA-PACIFIC EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 29: LATIN AMERICA EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 30: LATIN AMERICA EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 31: LATIN AMERICA EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)

TABLE 32: LATIN AMERICA EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)

TABLE 33: LATIN AMERICA EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 34: LATIN AMERICA EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 35: MIDDLE EAST AND AFRICA EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 36: MIDDLE EAST AND AFRICA EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 37: MIDDLE EAST AND AFRICA EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)

TABLE 38: MIDDLE EAST AND AFRICA EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)

TABLE 39: MIDDLE EAST AND AFRICA EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 40: MIDDLE EAST AND AFRICA EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: GLOBAL EUBIOTICS MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: GLOBAL EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $ MILLION)

FIGURE 4: GLOBAL EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN $ MILLION)

FIGURE 5: GLOBAL EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $ MILLION)

FIGURE 6: GLOBAL EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL EUBIOTICS MARKET, BY FORM, 2020 & 2028 (IN %)

FIGURE 8: GLOBAL EUBIOTICS MARKET, BY DRY, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL EUBIOTICS MARKET, BY LIVESTOCK, 2020 & 2028 (IN %)

FIGURE 11: GLOBAL EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL EUBIOTICS MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 17: GLOBAL EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL EUBIOTICS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL EUBIOTICS MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 22: GLOBAL EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 25: UNITED STATES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: CANADA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 27: UNITED KINGDOM EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: GERMANY EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: FRANCE EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: SPAIN EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: ITALY EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 32: RUSSIA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 33: REST OF EUROPE EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 34: CHINA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 35: JAPAN EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 36: INDIA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 37: SOUTH KOREA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 38: ASEAN COUNTRIES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 39: AUSTRALIA & NEW ZEALAND EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 40: REST OF ASIA-PACIFIC EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 41: BRAZIL EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 42: MEXICO EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 43: REST OF LATIN AMERICA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 44: UNITED ARAB EMIRATES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 45: SAUDI ARABIA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 46: TURKEY EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 47: SOUTH AFRICA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 48: REST OF MIDDLE EAST & AFRICA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying